Prognostic factor | Score |
|---|
Primary characteristicsa |
Slow1 | 0 |
Moderate2 | 2 |
Rapid3 | 3 |
Visceral metastases |
No | 0 |
Nodular | 1 |
Disseminated4 | 2 |
Laboratory data |
Normal | 0 |
Abnormal5 | 1 |
Critical6 | 2 |
ECOG PS |
0–2 | 0 |
3–4 | 1 |
Previous chemotherapy |
No | 0 |
Yes | 1 |
Multiple skeletal metastases |
No | 0 |
Yes | 1 |
Total | 10 |
- 1: Breast cancer, prostate cancer, thyroid cancer, multiple myeloma, and malignant lymphoma; 2:Renal cell carcinoma, endometrial and ovarian cancer, sarcoma, and others; 3: Lung cancer, colorectal cancer, gastric cancer, pancreatic cancer, head and neck cancer, esophageal cancer, other urological cancers, melanoma, hepatocellular carcinoma, gall bladder cancer, cervical cancer, and cancers of unknown origin; 4: Pleural, peritoneal, or leptomeningeal dissemination; 5: CRP ≥ 0.4 mg/dL, LDH ≥ 250 IU/L, or serum albumin < 3.7 g/dL; 6: platelet < 100,000/lL, serum calcium ≥10.3 mg/dL, or total bilirubin ≥1.4 mg/dL
- aNOTE. Primary characteristics are partially modified
